Subsequent Events - Additional Information (Details) - USD ($)		2 Months Ended	7 Months Ended	12 Months Ended
	Jan. 25, 2021	Mar. 01, 2021	Dec. 31, 2020	Dec. 31, 2020
At-the-Market Facility
Subsequent Event [Line Items]
Issuance of common stock, net of issuance costs, shares			1,838,957
Proceeds from issuance of common stock gross			$ 7,200,000
At-the-Market Facility | Weighted Average
Subsequent Event [Line Items]
Issuance of common stock, price per share			$ 3.9228	$ 3.9228
Lincoln Park
Subsequent Event [Line Items]
Issuance of common stock, net of issuance costs, shares				900,000
Issuance of common stock, price per share			2.64	$ 2.64
Proceeds from issuance of common stock gross				$ 2,400,000
Lincoln Park | Weighted Average
Subsequent Event [Line Items]
Issuance of common stock, price per share			$ 2.64	$ 2.64
Subsequent Event | At-the-Market Facility
Subsequent Event [Line Items]
Issuance of common stock, net of issuance costs, shares		877,107
Proceeds from issuance of common stock gross		$ 2,800,000
Subsequent Event | At-the-Market Facility | Weighted Average
Subsequent Event [Line Items]
Issuance of common stock, price per share		$ 3.17
Subsequent Event | Proposed Collaboration and License Agreement
Subsequent Event [Line Items]
Percentage of net profit split	40.00%
Subsequent Event | Proposed Collaboration and License Agreement | Relief Therapeutics Holding AG
Subsequent Event [Line Items]
Proposed agreement closing date	Jun. 30, 2021
Upfront non-refundable payment received	$ 1,000,000
Potential cash receivable	14,000,000
Potential offset to cash receivable	4,000,000
Maximum potential payment receivable for development and commercial launch costs	$ 20,000,000
Percentage of net profit split	60.00%
Percentage of royalty receivable on net sales	15.00%
Potential milestone payment receivable	$ 6,000,000
Subsequent Event | Proposed Collaboration and License Agreement | Relief Therapeutics Holding AG | Secured Loan
Subsequent Event [Line Items]
Debt instrument, term	12 months
Debt instrument, principal amount	$ 4,000,000
Debt instrument, interest rate	6.00%
Subsequent Event | Lincoln Park
Subsequent Event [Line Items]
Issuance of common stock, net of issuance costs, shares		200,000
Issuance of common stock, price per share		$ 2.47
Proceeds from issuance of common stock gross		$ 500,000